Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. (Q48903223)
Jump to navigation
Jump to search
scientific article published on 19 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. |
scientific article published on 19 January 2010 |
Statements
1 reference
Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. (English)
1 reference
T Hershcovici
1 reference
M Leshno
1 reference
E Goldin
1 reference
R Shamir
1 reference
E Israeli
1 reference
19 January 2010
1 reference
31
1 reference
8
1 reference
901-910
1 reference
Identifiers
1 reference
1 reference